JP2005517436A5 - - Google Patents

Download PDF

Info

Publication number
JP2005517436A5
JP2005517436A5 JP2003569803A JP2003569803A JP2005517436A5 JP 2005517436 A5 JP2005517436 A5 JP 2005517436A5 JP 2003569803 A JP2003569803 A JP 2003569803A JP 2003569803 A JP2003569803 A JP 2003569803A JP 2005517436 A5 JP2005517436 A5 JP 2005517436A5
Authority
JP
Japan
Prior art keywords
sina molecule
nucleotides
nucleotide
molecule
rna
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2003569803A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005517436A (ja
Filing date
Publication date
Priority claimed from PCT/US2002/017674 external-priority patent/WO2002096927A2/en
Priority claimed from US10/287,949 external-priority patent/US20040102389A1/en
Priority claimed from US10/306,747 external-priority patent/US20030216335A1/en
Application filed filed Critical
Priority claimed from PCT/US2003/005022 external-priority patent/WO2003070910A2/en
Publication of JP2005517436A publication Critical patent/JP2005517436A/ja
Publication of JP2005517436A5 publication Critical patent/JP2005517436A5/ja
Withdrawn legal-status Critical Current

Links

JP2003569803A 2002-02-20 2003-02-20 短干渉核酸（ｓｉＮＡ）を用いた血管内皮成長因子および血管内皮成長因子レセプター遺伝子発現のＲＮＡ干渉媒介阻害 Withdrawn JP2005517436A (ja)

Applications Claiming Priority (13)

Application Number Priority Date Filing Date Title
US35858002P 2002-02-20 2002-02-20
US36312402P 2002-03-11 2002-03-11
PCT/US2002/017674 WO2002096927A2 (en) 2001-05-29 2002-05-29 Ribozyme based treatment of female reproductive diseases
US38678202P 2002-06-06 2002-06-06
US39379602P 2002-07-03 2002-07-03
US39934802P 2002-07-29 2002-07-29
US40678402P 2002-08-29 2002-08-29
US40837802P 2002-09-05 2002-09-05
US40929302P 2002-09-09 2002-09-09
US10/287,949 US20040102389A1 (en) 1995-10-26 2002-11-04 Nucleic acid-mediated treatment of diseases or conditions related to levels of vascular endothelial growth factor receptor (VEGF-R)
US10/306,747 US20030216335A1 (en) 2001-11-30 2002-11-27 Method and reagent for the modulation of female reproductive diseases and conditions
US44012903P 2003-01-15 2003-01-15
PCT/US2003/005022 WO2003070910A2 (en) 2002-02-20 2003-02-20 INHIBITION OF VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) AND VEGF RECEPTOR GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2008148548A Division JP2009000105A (ja) 2002-02-20 2008-06-05 短干渉核酸（ｓｉＮＡ）を用いた血管内皮成長因子および血管内皮成長因子レセプター遺伝子発現のＲＮＡ干渉媒介阻害

Publications (2)

Publication Number Publication Date
JP2005517436A JP2005517436A (ja) 2005-06-16
JP2005517436A5 true JP2005517436A5 (OSRAM) 2006-09-21

Family

ID=40427642

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2003569803A Withdrawn JP2005517436A (ja) 2002-02-20 2003-02-20 短干渉核酸（ｓｉＮＡ）を用いた血管内皮成長因子および血管内皮成長因子レセプター遺伝子発現のＲＮＡ干渉媒介阻害
JP2008148548A Pending JP2009000105A (ja) 2002-02-20 2008-06-05 短干渉核酸（ｓｉＮＡ）を用いた血管内皮成長因子および血管内皮成長因子レセプター遺伝子発現のＲＮＡ干渉媒介阻害

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2008148548A Pending JP2009000105A (ja) 2002-02-20 2008-06-05 短干渉核酸（ｓｉＮＡ）を用いた血管内皮成長因子および血管内皮成長因子レセプター遺伝子発現のＲＮＡ干渉媒介阻害

Country Status (6)

Country Link
US (1) US20030216335A1 (OSRAM)
EP (1) EP1521768A4 (OSRAM)
JP (2) JP2005517436A (OSRAM)
AU (1) AU2003216323B2 (OSRAM)
CA (1) CA2456444A1 (OSRAM)
GB (2) GB2406569B (OSRAM)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005019453A2 (en) * 2001-05-18 2005-03-03 Sirna Therapeutics, Inc. RNA INTERFERENCE MEDIATED INHIBITION OF GENE EXPRESSION USING CHEMICALLY MODIFIED SHORT INTERFERING NUCLEIC ACID (siNA)
US20050222066A1 (en) * 2001-05-18 2005-10-06 Sirna Therapeutics, Inc. RNA interference mediated inhibition of vascular endothelial growth factor and vascular endothelial growth factor receptor gene expression using short interfering nucleic acid (siNA)
US20050054596A1 (en) * 2001-11-30 2005-03-10 Mcswiggen James RNA interference mediated inhibition of vascular endothelial growth factor and vascular endothelial growth factor receptor gene expression using short interfering nucleic acid (siNA)
US20050148530A1 (en) * 2002-02-20 2005-07-07 Sirna Therapeutics, Inc. RNA interference mediated inhibition of vascular endothelial growth factor and vascular endothelial growth factor receptor gene expression using short interfering nucleic acid (siNA)
US20050075304A1 (en) * 2001-11-30 2005-04-07 Mcswiggen James RNA interference mediated inhibition of vascular endothelial growth factor and vascular endothelial growth factor receptor gene expression using short interfering nucleic acid (siNA)
US20070203333A1 (en) * 2001-11-30 2007-08-30 Mcswiggen James RNA interference mediated inhibition of vascular endothelial growth factor and vascular endothelial growth factor receptor gene expression using short interfering nucleic acid (siNA)
US20040138163A1 (en) * 2002-05-29 2004-07-15 Mcswiggen James RNA interference mediated inhibition of vascular edothelial growth factor and vascular edothelial growth factor receptor gene expression using short interfering nucleic acid (siNA)
ES2397060T3 (es) * 2002-04-18 2013-03-04 Opko Pharmaceuticals, Llc Medios y métodos para la modulación específica de genes diana en el ojo
US7148342B2 (en) * 2002-07-24 2006-12-12 The Trustees Of The University Of Pennyslvania Compositions and methods for sirna inhibition of angiogenesis
EP1711172A4 (en) * 2003-12-23 2008-07-16 Univ Pennsylvania COMPOSITIONS AND METHODS FOR COMBINATION THERAPY OF ILLNESSES
EP1774036A4 (en) * 2004-06-14 2008-10-15 Univ Texas At Austin GEN-TARGETING IN EUKARYOTIC CELLS BY GROUP II INTRON-RIBONUCLEOPROTEIN PARTICLES
EP1774016A2 (en) * 2004-06-14 2007-04-18 The University Of Texas At Austin Methods for expressing rnp particles in eukaryotic cells
CN101346393B (zh) 2005-11-02 2015-07-22 普洛体维生物治疗公司 修饰的siRNA分子及其应用
ES2390499T3 (es) * 2006-06-12 2012-11-13 Opko Pharmaceuticals, Llc Composiciones y métodos para la inhibición de la angiogénesis por sirna
US7872118B2 (en) * 2006-09-08 2011-01-18 Opko Ophthalmics, Llc siRNA and methods of manufacture
US20080287408A1 (en) * 2007-05-14 2008-11-20 Drugtech Corporation Endometriosis treatment
PL2279254T3 (pl) 2008-04-15 2017-11-30 Protiva Biotherapeutics Inc. Nowe preparaty lipidowe do dostarczania kwasów nukleinowych
US20110200612A1 (en) 2008-06-30 2011-08-18 Michael Schuster Treatment of eye diseases and excessive neovascularization using combined therapy
ES2600781T3 (es) * 2008-12-04 2017-02-10 Curna, Inc. Tratamiento para enfermedades relacionadas con el factor de crecimiento del endotelio vascular (vegf) mediante la inhibición de transcritos antisentido naturales de vegf
JP5832293B2 (ja) * 2008-12-04 2015-12-16 オプコ ファーマシューティカルズ、エルエルシー 血管新生促進ｖｅｇｆイソ型を選択的に抑制する組成物および方法
JP5766188B2 (ja) 2009-07-01 2015-08-19 プロチバ バイオセラピューティクス インコーポレイティッド 固形腫瘍に治療剤を送達するための脂質製剤
CA2775092A1 (en) 2009-09-23 2011-03-31 Protiva Biotherapeutics, Inc. Compositions and methods for silencing genes expressed in cancer
JP6002382B2 (ja) * 2011-12-07 2016-10-05 株式会社バイオシンクタンク 遺伝子発現阻害剤及び阻害方法
EP3473611B1 (en) 2012-02-24 2021-10-20 Arbutus Biopharma Corporation Trialkyl cationic lipids and methods of use thereof
MX2019009305A (es) 2017-02-06 2019-09-19 Nissan Chemical Corp Oligonucleotido de cadena simple.
WO2021188389A2 (en) 2020-03-17 2021-09-23 Genevant Sciences Gmbh Cationic lipids for lipid nanoparticle delivery of therapeutics to hepatic stellate cells
US20240148663A1 (en) 2020-12-18 2024-05-09 Genevant Sciences Gmbh Peg lipids and lipid nanoparticles
US20250332112A1 (en) 2022-01-31 2025-10-30 Genevant Sciences Gmbh Ionizable cationic lipids for lipid nanoparticles
WO2025052278A1 (en) 2023-09-05 2025-03-13 Genevant Sciences Gmbh Pyrrolidine based cationic lipids for lipid nanoparticle delivery of therapeutics to hepatic stellate cells
WO2025133951A1 (en) 2023-12-21 2025-06-26 Genevant Sciences Gmbh Ionizable lipids suitable for lipid nanoparticles

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030206887A1 (en) * 1992-05-14 2003-11-06 David Morrissey RNA interference mediated inhibition of hepatitis B virus (HBV) using short interfering nucleic acid (siNA)
WO1997021808A1 (en) * 1995-12-08 1997-06-19 Hybridon, Inc. Modified vegf antisense oligonucleotides
DE19956568A1 (de) * 1999-01-30 2000-08-17 Roland Kreutzer Verfahren und Medikament zur Hemmung der Expression eines vorgegebenen Gens
US20030190635A1 (en) * 2002-02-20 2003-10-09 Mcswiggen James A. RNA interference mediated treatment of Alzheimer's disease using short interfering RNA
JP2005500025A (ja) * 2001-05-29 2005-01-06 サーナ・セラピューティクス・インコーポレイテッド 女性生殖疾病及び状態の核酸に基づく調節
US7148342B2 (en) * 2002-07-24 2006-12-12 The Trustees Of The University Of Pennyslvania Compositions and methods for sirna inhibition of angiogenesis

Similar Documents

Publication Publication Date Title
JP2005517436A5 (OSRAM)
JP2005517432A5 (OSRAM)
JP2005517438A5 (OSRAM)
JP2005517433A5 (OSRAM)
JP2006502694A5 (OSRAM)
JP2005517427A5 (OSRAM)
JP2005517452A5 (OSRAM)
US12492425B2 (en) Methods for RNA analysis
JP2005517430A5 (OSRAM)
JP2005524393A5 (OSRAM)
JP2005500025A5 (OSRAM)
JP6752957B2 (ja) オリゴヌクレオチドの産生のための新規プロセス
CA2457528A1 (en) Rna interference mediated inhibition of hepatitis c virus (hcv) gene expression using short interfering nucleic acid (sina)
JP2010503382A5 (OSRAM)
EP2407558A1 (en) Methods for the detection of a single- or double-stranded nucleic acid molecule
JP2007529224A5 (OSRAM)
JP2008283975A5 (OSRAM)
JP2005518803A5 (OSRAM)
EP1737879A2 (en) Aptamer-mediated intracellular delivery of therapeutic oligonucleotides
CA2526831A1 (en) Rna interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (sina)
JP2013535212A5 (OSRAM)
JP7033591B2 (ja) 治療用オリゴヌクレオチドの捕捉および検出
WO2013142735A1 (en) Targeting domain and related signal activated molecular delivery
EP3449002A1 (en) G-quadruplex-containing antisense oligonucleotides
WO2003070888B1 (en) Rna interference mediated inhibition of checkpoint kinase-1 (chk-1) gene expression using short interfering nucleic acid